First Citizens BancShares Inc vs Tilray Brands Inc — how do they compare? First Citizens BancShares Inc trades at $2,124.52 (market cap $23.76B), while Tilray Brands Inc trades at $4.39 (market cap $541.36M). The key difference: First Citizens BancShares Inc is far larger — about 43.9× Tilray Brands Inc's market cap, and First Citizens BancShares Inc pays a 0.41% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| FCNCA | TLRY | |
|---|---|---|
Market Cap | $23.76B | $541.36M |
Sector | Sector/Thematic | Health |
52-Week High | $2.20K | $21.00 |
52-Week Low | $1.64K | $4.31 |
Dividend Yield | 0.41% | — |
Enterprise Value | — | $638.50M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.355, down 0.57% on the day, amid a bearish technical signal and weak earnings performance. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, while revenue grew to $821.31 million. Recent news includes medical cannabis expansion in Panama and the acquisition of HelloMD to enhance digital healthcare capabilities.
The outlook remains challenging due to persistent losses and high debt levels, though low valuation ratios like P/S of 0.55 and P/B of 0.35 may attract value investors. Key risks include profitability struggles, regulatory uncertainty, and competitive pressures in the cannabis sector. Analyst sentiment is mixed, with 65% hold ratings reflecting caution.
Trailing returns across standard periods
Latest headlines on both assets
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →